Revisiting ECTRIMS Congress 2025 MStranslate November 18, 2025 ECTRIMS, Podcasts, Research Between September 23 and 26, 2025, the 41st annual ECTRIMS Congress took place in Barcelona, Spain, co-convened by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and...
UPDATED: The ECTRIMS Podcast – Episode Library MStranslate September 10, 2025 ECTRIMS, Podcasts, Research Prior to the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2022, held in Amsterdam, The Netherlands, we announced that our co-founder, Brett Drummond, had been invited...
Patient Community Day at ECTRIMS 2025 MStranslate July 22, 2025 ECTRIMS, Events, Research As many will be aware, MStranslate has had the privilege of partnering with the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) since 2022. The ECTRIMS Podcast This close...
Multiple Sclerosis in 2025 – Key Developments to Date MStranslate May 7, 2025 Cambridge, ECTRIMS, Remyelination, Research 1 Comment In approximately 3 weeks, we will be celebrating World Multiple Sclerosis Day. The theme in 2025 is ‘Navigating MS Together’, which perfectly aligns with everything that we stand for at MStranslate. In...
Diet & Clinical Outcomes in Multiple Sclerosis MStranslate November 13, 2024 Diet, Lifestyle, Research Research Summary: A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective...
Study Provides New Insights Into Disease Progression MStranslate November 6, 2024 Research Research Summary: Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis While we now have a number of treatments for multiple sclerosis, there is still...
Bile Acids: A Novel Multiple Sclerosis Therapy? MStranslate August 6, 2024 Research, Treatments Research Summary: Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease Researchers are constantly looking at novel approaches for the treatment of...
Long-term HSCT Outcomes in Norway MStranslate July 9, 2024 Research, Stem Cells, Treatments Research Summary: Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway Although not a new treatment approach, haematopoietic stem cell...
‘Wearing Off’ Of MS Treatments Between Doses MStranslate July 1, 2024 Research, Treatments Research Summary: The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis One of the major developments in the treatment of multiple sclerosis has been the...
Retinoic Acid and Calcitriol May Promote Remyelination MStranslate June 25, 2024 Remyelination, Research, Treatments Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal...
